MCID: PRV003
MIFTS: 41

Perivascular Epithelioid Cell Tumor

Categories: Cancer diseases

Aliases & Classifications for Perivascular Epithelioid Cell Tumor

MalaCards integrated aliases for Perivascular Epithelioid Cell Tumor:

Name: Perivascular Epithelioid Cell Tumor 12 15
Perivascular Epithelioid Cell Neoplasms 44 73
Neoplasm with Perivascular Epithelioid Cell Differentiation 12
Pecoma 12

Classifications:



External Ids:

Disease Ontology 12 DOID:2643
MeSH 44 D054973
NCIt 50 C38150
SNOMED-CT 68 388601000
UMLS 73 C1300127

Summaries for Perivascular Epithelioid Cell Tumor

MalaCards based summary : Perivascular Epithelioid Cell Tumor, also known as perivascular epithelioid cell neoplasms, is related to tuberous sclerosis and angiosarcoma. An important gene associated with Perivascular Epithelioid Cell Tumor is TSC2 (TSC Complex Subunit 2), and among its related pathways/superpathways are Cytoskeletal Signaling and Aurora B signaling. The drugs Everolimus and Miconazole have been mentioned in the context of this disorder. Affiliated tissues include liver, uterus and lung, and related phenotypes are cardiovascular system and muscle

Related Diseases for Perivascular Epithelioid Cell Tumor

Diseases related to Perivascular Epithelioid Cell Tumor via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 248)
# Related Disease Score Top Affiliating Genes
1 tuberous sclerosis 30.1 SYP TSC2 VIM
2 angiosarcoma 30.0 KIT MUC1 VIM
3 lymphangioleiomyomatosis 30.0 DES PGR TSC2
4 alveolar soft part sarcoma 30.0 DES SYP VIM
5 pneumothorax 29.8 MUC1 PGR VIM
6 gastrointestinal stromal tumor 28.7 ACTC1 DES KIT SYP VIM
7 angiomyolipoma 28.6 ACTC1 DES KIT PGR TSC2
8 smooth muscle tumor 28.4 ACTC1 DES KIT PGR VIM
9 leiomyoma 26.9 ACTC1 DES KIT MME PGR VIM
10 uterus perivascular epithelioid cell tumor 12.3
11 lymphangiectasis 10.8 ACTC1 VIM
12 glomangiomyoma 10.8 ACTC1 VIM
13 intravascular papillary endothelial hyperplasia 10.8 ACTC1 VIM
14 malignant peritoneal mesothelioma 10.7 MUC1 VIM
15 fibroblastic rheumatism 10.7 ACTC1 DES
16 botryoid rhabdomyosarcoma 10.7 ACTC1 DES
17 fibrous meningioma 10.7 MUC1 VIM
18 nodular hidradenoma 10.7 MUC1 VIM
19 eccrine porocarcinoma 10.7 MUC1 VIM
20 infantile digital fibromatosis 10.7 DES VIM
21 primitive neuroectodermal tumor of the cervix uteri 10.7 DES VIM
22 myxopapillary ependymoma 10.7 MUC1 VIM
23 monophasic synovial sarcoma 10.7 MUC1 VIM
24 spiradenoma 10.7 MUC1 VIM
25 hidradenoma 10.6 MUC1 VIM
26 spindle cell thymoma 10.6 DES MUC1
27 mucinous cystadenocarcinoma 10.6 MUC1 VIM
28 spindle cell rhabdomyosarcoma 10.6 DES MUC1
29 juvenile xanthogranuloma 10.6 DES VIM
30 non-langerhans-cell histiocytosis 10.6 ACTC1 DES
31 chondroid chordoma 10.6 MUC1 VIM
32 proximal spinal muscular atrophy 10.6 DES MUC1
33 mast-cell sarcoma 10.5 KIT VIM
34 granular cell tumor 10.5 DES VIM
35 primary hepatic neuroendocrine carcinoma 10.5 SYP VIM
36 plasmablastic lymphoma 10.5 DES MUC1
37 rhabdoid meningioma 10.5 SYP VIM
38 reticular perineurioma 10.5 KIT MUC1
39 sinonasal undifferentiated carcinoma 10.5 MUC1 SYP
40 astroblastoma 10.5 SYP VIM
41 benign mesothelioma 10.5 MUC1 VIM
42 middle ear adenoma 10.5 MUC1 SYP
43 melanotic neuroectodermal tumor 10.5 SYP VIM
44 aggressive digital papillary adenocarcinoma 10.5 KIT MUC1
45 senile angioma 10.5 KIT VIM
46 sarcomatoid renal cell carcinoma 10.5 KIT MUC1
47 medulloepithelioma 10.5 SYP VIM
48 gallbladder sarcoma 10.5 DES KIT
49 calcifying aponeurotic fibroma 10.5 ACTC1 PGR
50 secretory meningioma 10.4 MUC1 VIM

Graphical network of the top 20 diseases related to Perivascular Epithelioid Cell Tumor:



Diseases related to Perivascular Epithelioid Cell Tumor

Symptoms & Phenotypes for Perivascular Epithelioid Cell Tumor

MGI Mouse Phenotypes related to Perivascular Epithelioid Cell Tumor:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.43 ACTC1 DES KIT PGR TSC2 VIM
2 muscle MP:0005369 9.02 ACTC1 DES KIT PGR VIM

Drugs & Therapeutics for Perivascular Epithelioid Cell Tumor

Drugs for Perivascular Epithelioid Cell Tumor (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 81)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Everolimus Approved Phase 4,Phase 3,Phase 2,Phase 1 159351-69-6 6442177
2
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
3
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 53123-88-9 5284616 6436030 46835353
4
Doxycycline Approved, Investigational, Vet_approved Phase 4 564-25-0 54671203
5 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1
6 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 2,Phase 1
7 Antifungal Agents Phase 4,Phase 3,Phase 2,Phase 1
8 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1
9 Immunosuppressive Agents Phase 4,Phase 3,Phase 2,Phase 1
10 Antimalarials Phase 4,Phase 1
11 Antiparasitic Agents Phase 4,Phase 1
12 Antiprotozoal Agents Phase 4,Phase 1
13
Doxorubicin Approved, Investigational Phase 3,Phase 2 23214-92-8 31703
14
Trabectedin Approved, Investigational Phase 3 114899-77-3 108150
15
Cyclophosphamide Approved, Investigational Phase 2, Phase 3 50-18-0, 6055-19-2 2907
16
Ifosfamide Approved Phase 2, Phase 3 3778-73-2 3690
17
Mechlorethamine Approved, Investigational Phase 2, Phase 3 51-75-2 4033
18
Doxil Approved June 1999 Phase 3,Phase 2 31703
19 Alkylating Agents Phase 3,Phase 2
20 Antineoplastic Agents, Alkylating Phase 3,Phase 2
21
Isophosphamide mustard Phase 2, Phase 3 0
22 Topoisomerase Inhibitors Phase 2, Phase 3
23
Propranolol Approved, Investigational Phase 2 525-66-6 4946
24
Letrozole Approved, Investigational Phase 2 112809-51-5 3902
25
Octreotide Approved, Investigational Phase 2 83150-76-9 383414 6400441
26
Somatostatin Approved, Investigational Phase 2 38916-34-6, 51110-01-1 53481605
27
Menthol Approved Phase 2,Not Applicable 2216-51-5 16666
28
Resveratrol Approved, Experimental, Investigational Phase 2 501-36-0 445154
29
Nintedanib Approved Phase 2 656247-17-5 56843413
30
Celecoxib Approved, Investigational Phase 2 169590-42-5 2662
31
Simvastatin Approved Phase 1, Phase 2 79902-63-9 54454
32
Saracatinib Investigational Phase 2,Phase 1 379231-04-6
33 Adrenergic Agents Phase 2
34 Adrenergic Antagonists Phase 2
35 Adrenergic beta-Antagonists Phase 2
36 Angiogenesis Inhibitors Phase 2
37 Anti-Arrhythmia Agents Phase 2
38 Antihypertensive Agents Phase 2
39 Neurotransmitter Agents Phase 2
40 Vasodilator Agents Phase 2
41 Aromatase Inhibitors Phase 2
42 Estrogen Antagonists Phase 2
43 Estrogens Phase 2
44 Hormone Antagonists Phase 2
45 Hormones Phase 2
46 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 2
47 Steroid Synthesis Inhibitors Phase 2
48 Antineoplastic Agents, Hormonal Phase 2
49 Gastrointestinal Agents Phase 2
50 Antirheumatic Agents Phase 2,Phase 1

Interventional clinical trials:

(show all 46)
# Name Status NCT ID Phase Drugs
1 Rapamycin In Angiomyolipomas In Patients With Tuberous Sclerosis Completed NCT01217125 Phase 4 Sirolimus
2 Doxycycline In Lymphangioleiomyomatosis (LAM) Completed NCT00989742 Phase 4 Doxycycline;Placebo
3 Phase IV Study of Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex. Not yet recruiting NCT03525834 Phase 4 everolimus
4 Efficacy and Safety of Sirolimus for Treating Lymphangioleiomyomatosis (LAM) Unknown status NCT00414648 Phase 3 Sirolimus;Placebo sirolimus
5 Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM) Completed NCT00790400 Phase 3 Everolimus (RAD001);Everolimus Placebo
6 Trabectedin Maintenance Post 1st-line in STS Recruiting NCT02929394 Phase 3 Trabectedin
7 Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Recruiting NCT02180867 Phase 2, Phase 3 Doxorubicin Hydrochloride;Ifosfamide;Pazopanib Hydrochloride
8 Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial Recruiting NCT03150914 Phase 3 Sirolimus
9 Sirolimus in Treating Patients With Angiomyolipoma of the Kidney Unknown status NCT00126672 Phase 2 sirolimus
10 Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM Unknown status NCT00490789 Phase 2 sirolimus
11 Treatment of Renal Angiomyolipomas in Tuberous Sclerosis by Beta-blockers Completed NCT02104011 Phase 2 Propranolol
12 Trial of Aromatase Inhibition in Lymphangioleiomyomatosis Completed NCT01353209 Phase 2 Letrozole;Placebo
13 A Study to Determine the Effectiveness of Escalating Doses of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis Completed NCT01059318 Phase 2 Everolimus;Everolimus;Everolimus
14 Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM) Completed NCT00792766 Phase 1, Phase 2 everolimus (RAD001)
15 RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM Completed NCT00457964 Phase 1, Phase 2 RAD001
16 Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM Completed NCT00457808 Phase 2 Rapamycin, sirolimus
17 Treatment With Octreotide in Patients With Lymphangioleiomyomatosis Completed NCT00005906 Phase 2 Octreotide
18 A Phase 2 Study of ABI-009 in Patients With Advanced Malignant PEComa Recruiting NCT02494570 Phase 2 ABI-009
19 Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on Everolimus Recruiting NCT02539459 Phase 2 Everolimus
20 Resveratrol and Sirolimus in Lymphangioleiomyomatosis Trial Recruiting NCT03253913 Phase 2 Sirolimus;Resveratrol
21 LAM Pilot Study With Imatinib Mesylate Recruiting NCT03131999 Phase 1, Phase 2 Imatinib Mesylate 400Mg Capsule;Placebo - Capsule
22 A Study of Nintedanib for LymphAngioleioMyomatosis (LAM) Recruiting NCT03062943 Phase 2 Nintedanib
23 Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis Recruiting NCT02737202 Phase 2 saracatinib
24 COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSC Recruiting NCT02484664 Phase 2 Celecoxib
25 Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis Recruiting NCT01799538 Phase 2 albuterol inhaler;albuterol nebulizer
26 Safety of Simvastatin in LAM and TSC Recruiting NCT02061397 Phase 1, Phase 2 Simvastatin
27 A Phase II Study of Orally Administered BEZ235 Monotherapy in Patients With Metastatic or Unresectable Malignant PEComa Withdrawn NCT01690871 Phase 2 BEZ235
28 The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1) Completed NCT02116712 Phase 1 Saracatinib
29 Safety Study of Sirolimus and Hydroxychloroquine in Women With Lymphangioleiomyomatosis Completed NCT01687179 Phase 1 sirolimus and hydroxychloroquine
30 The Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation (ECMO) on Coronary Oxygenation in Lung Transplantation Patients Unknown status NCT02859194 Not Applicable
31 Evaluation of New Biomarkers Predictive of Efficacy Betablockers in PEComa and Vascular Pediatric Tumors Completed NCT02334930
32 Pulmonary Rehabilitation in Lymphangioleiomyomatosis Completed NCT02009241 Not Applicable
33 Pulmonary Hypertension in Lymphangioleiomyomatosis Completed NCT00960895
34 Effect of Fasting on the Size of Abdominal Lymphatic Tumors in Women Completed NCT00552955
35 Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases Completed NCT00366509
36 Official Record of Patients Diagnosed With Lymphangioleiomyomatosis (LAM) Completed NCT00001869
37 Lymphangioleiomyomatosis (LAM) Registry Completed NCT00005486
38 Discovery of Sirolimus Sensitive Biomarkers in Blood Recruiting NCT03304678
39 A National Registry on Chinese Patients With Lymphangioleiomyomatosis Recruiting NCT03193892
40 EASYX-1 : A Multicenter Study on Safety and Efficacy of Easyx Liquid Embolization Agent Used in Five Separate Indications Recruiting NCT03477149 Not Applicable
41 Safety and Durability of Sirolimus for Treatment of LAM Recruiting NCT02432560 Sirolimus;Everolimus
42 Clinical Presentation and Renal Outcome of Patients With Tuberous Sclerosis Complex and/or Renal Angiomyolipoma in the Great West Region of France Recruiting NCT02887781
43 Lymphatic Anomalies Registry Recruiting NCT02399527
44 Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma Recruiting NCT02325505
45 National Lymphangioleiomyomatosis Registry, France Recruiting NCT01484236
46 Study of the Disease Process of Lymphangioleiomyomatosis Recruiting NCT00001465

Search NIH Clinical Center for Perivascular Epithelioid Cell Tumor

Cochrane evidence based reviews: perivascular epithelioid cell neoplasms

Genetic Tests for Perivascular Epithelioid Cell Tumor

Anatomical Context for Perivascular Epithelioid Cell Tumor

MalaCards organs/tissues related to Perivascular Epithelioid Cell Tumor:

41
Liver, Uterus, Lung, Kidney, Colon, Cervix, Pancreas

Publications for Perivascular Epithelioid Cell Tumor

Articles related to Perivascular Epithelioid Cell Tumor:

(show top 50) (show all 203)
# Title Authors Year
1
A rare case of perivascular epithelioid cell tumor (PEComa) of the greater omentum. ( 29921303 )
2018
2
Recurrence of retroperitoneal localized perivascular epithelioid cell tumor two years after initial diagnosis: case report. ( 29340502 )
2018
3
Hepatobiliary and Pancreatic: Malignant pancreatic perivascular epithelioid cell tumor mimicking pancreatic neuroendocrine tumor. ( 29888489 )
2018
4
Prolonged activity and toxicity of sirolimus in a patient with metastatic renal perivascular epithelioid cell tumor: a case report and literature review. ( 29668485 )
2018
5
Primary pancreatic perivascular epithelioid cell tumor (PEComa): A surgical enigma. A systematic review of the literature. ( 29478828 )
2018
6
Primary malignant perivascular epithelioid cell neoplasm (PEComa) of the bone mimicking granular cell tumor in core biopsy: A case report and literature review. ( 29435023 )
2018
7
Perirenal perivascular epithelioid cell tumor (PEComa) coexisting with other malignancies: a case report. ( 28547987 )
2017
8
Malignant perivascular epithelioid cell tumor of the oropharynx with strong TFE3 expression mimicking alveolar soft part sarcoma: a case report and review of the literature. ( 29208563 )
2017
9
Malignant perivascular epithelioid cell tumor of the orbit: Report of a case and review of literature. ( 28905842 )
2017
10
Cardiac Perivascular Epithelioid Cell Tumor. ( 28415905 )
2017
11
Two cases of perivascular epithelioid cell tumor of the uterus: clinical, radiological and pathological diagnostic challenge. ( 28270196 )
2017
12
Liver Perivascular Epithelioid Cell Tumor with an Unusual Location: Diagnostic Characteristics with Multidetector Computed Tomography and Magnetic Resonance Imaging. ( 28975043 )
2017
13
Case of lymph node primary perivascular epithelioid cell tumor associated with leukoderma. ( 28868802 )
2017
14
An orbital perivascular epithelioid cell tumor in a 7-year-old boy: case report and review of the literature. ( 28576480 )
2017
15
Computed tomography imaging features of hepatic perivascular epithelioid cell tumor: A case report and literature review. ( 29245304 )
2017
16
Primary cutaneous perivascular epithelioid cell tumor (PEComa): Five new cases and review of the literature. ( 28556973 )
2017
17
Perivascular Epithelioid Cell Tumor (PEComa) of the Uterine Cervix: A Case Report of a 43-Yr-Old Woman With Abnormal Uterine Bleeding Treated With Hysterectomy. ( 28787320 )
2017
18
Perivascular Epithelioid Cell Tumor in the Stomach. ( 28372349 )
2017
19
Pneumothorax caused by cystic and nodular lung metastases from a malignant uterine perivascular epithelioid cell tumor (PEComa). ( 28706850 )
2017
20
Hepatic perivascular epithelioid cell tumor treated by transarterial embolization plus radiofrequency ablation: A case report and literature review. ( 28562547 )
2017
21
Hepatic perivascular epithelioid cell tumor (PEComa): a case report with a review of literatures. ( 28288506 )
2017
22
Broad Ligament Perivascular Epithelioid Cell Tumor (PEComa) of Uncertain Malignant Potential. ( 26832182 )
2016
23
Perivascular epithelioid cell tumor of the ileum. A case report. ( 26900883 )
2016
24
Pigmented perivascular epithelioid cell tumor (PEComa) arising from kidney: A case report. ( 27858882 )
2016
25
Hepatic perivascular epithelioid cell tumor: Case report and brief literature review. ( 28002331 )
2016
26
Hepatic perivascular epithelioid cell tumor in three patients. ( 27919857 )
2016
27
Cutaneous Perivascular Epithelioid Cell Tumor of Gynecologic Origin Metastatic to Skin, Lung, Stomach, and Brain. ( 27149334 )
2016
28
Perivascular Epithelioid Cell Tumor (PEComa) of Pancreas Diagnosed Preoperatively by Endoscopic Ultrasound-Guided Fine-Needle Aspiration: A Case Report and Review of Literature. ( 27628738 )
2016
29
Intrahepatic peribiliary perivascular epithelioid cell tumor (PEComa) associated with heterotopic pancreas: A case report. ( 27542598 )
2016
30
Sclerosing Perivascular Epithelioid Cell Tumor of the Lung: A Case Report with Cytologic Findings. ( 27068025 )
2016
31
Primary Perivascular Epithelioid Cell Tumor (PEComa) of the Bladder: A Case Report With 2-Years of Follow-Up and Review of Current Literature. ( 27793610 )
2016
32
Perivascular epithelioid cell tumor of the descending colon mimicking a gastrointestinal stromal tumor: a case report. ( 27842558 )
2016
33
Pancreatic perivascular epithelioid cell tumor: A case report with clinicopathological features and a literature review. ( 27053862 )
2016
34
A systematic review: perivascular epithelioid cell tumor of gastrointestinal tract. ( 27428182 )
2016
35
Perivascular epithelioid cell tumor of the uterus: Report of two cases and mini-review of the literature. ( 27689526 )
2016
36
Treatment of Advanced Malignant Uterine Perivascular Epithelioid Cell Tumor with mTOR Inhibitors: Single-institution Experience and Review of the Literature. ( 27793946 )
2016
37
Long-lasting stable disease with mTOR inhibitor treatment in a patient with a perivascular epithelioid cell tumor: A case report and literature review. ( 28105182 )
2016
38
Perivascular Epithelioid Cell Tumor of the Uterus with Ovarian Involvement: A Case Report and Review of the Literature. ( 27150246 )
2016
39
Pigmented Perivascular Epithelioid Cell Tumor of the Skin: First Case Report. ( 26355762 )
2015
40
Perivascular Epithelioid Cell Tumor of the Liver. ( 26601751 )
2015
41
Perivascular epithelioid cell tumor in the duodenum: challenge in differential diagnosis. ( 26339433 )
2015
42
Coincidence between malignant perivascular epithelioid cell tumor arising in the gastric serosa and lung adenocarcinoma. ( 25632212 )
2015
43
Hepatic perivascular epithelioid cell tumor: five case reports and literature review. ( 25554668 )
2015
44
Malignant perivascular epithelioid cell tumor (PEComa) of the femur: a case report and literature review. ( 26022435 )
2015
45
Improving recognition of hepatic perivascular epithelioid cell tumor: Case report and literature review. ( 25954119 )
2015
46
Perivascular Epithelioid Cell Tumor Masquerading as Retained Placenta. ( 26206840 )
2015
47
Malignant perivascular epithelioid cell tumor arising in the mesentery: A case report. ( 26137038 )
2015
48
TFE3 translocation-associated perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: morphology, immunophenotype, differential diagnosis. ( 25517951 )
2015
49
HMB-45 negative multifocal malignant perivascular epithelioid cell tumor of the soft tissue responding to sirolimus: First case report from India. ( 26881640 )
2015
50
Perivascular epithelioid cell tumor of gastrointestinal tract: case report and review of the literature. ( 25621681 )
2015

Variations for Perivascular Epithelioid Cell Tumor

Expression for Perivascular Epithelioid Cell Tumor

Search GEO for disease gene expression data for Perivascular Epithelioid Cell Tumor.

Pathways for Perivascular Epithelioid Cell Tumor

Pathways related to Perivascular Epithelioid Cell Tumor according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.75 ACTC1 DES MUC1 VIM
2
Show member pathways
10.81 DES VIM
3 10.66 ACTC1 DES VIM

GO Terms for Perivascular Epithelioid Cell Tumor

Cellular components related to Perivascular Epithelioid Cell Tumor according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 neuron projection terminus GO:0044306 8.62 MME SYP

Biological processes related to Perivascular Epithelioid Cell Tumor according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 intermediate filament organization GO:0045109 8.96 DES VIM
2 muscle filament sliding GO:0030049 8.8 ACTC1 DES VIM

Sources for Perivascular Epithelioid Cell Tumor

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....